These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 38558547

  • 41. Increase in Invasive Group A Streptococcal Disease and Emergence of Mucoid Strains in a Pediatric Population: February-June 2017.
    Walker LW, Montoya L, Chochua S, Beall B, Green M.
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz275. PubMed ID: 31281869
    [Abstract] [Full Text] [Related]

  • 42. Epidemiology of Group A Streptococcal bacteraemia in Hunter New England Local Health District, 2008 to 2019.
    Williamson KM, Varadhan H, Taylor K, Crooks K, Brett K, Law C, Butler M, Butler T, Green E, Davis JS, Wilson P, Housen T, Merritt T, Durrheim DN.
    Commun Dis Intell (2018); 2023 Aug 24; 47():. PubMed ID: 37817312
    [Abstract] [Full Text] [Related]

  • 43. Invasive Group A Streptococcus in Infants Less Than 1-year of Age From 2012 to 2022: A Single-Center Experience.
    Nack T, Vallejo JG, Dunn J, Flores AR, McNeil JC.
    J Pediatric Infect Dis Soc; 2024 Jan 29; 13(1):110-113. PubMed ID: 37978871
    [Abstract] [Full Text] [Related]

  • 44. Estimating the risk of invasive group A Streptococcus infection in care home residents in England, 2009-2010.
    Saavedra-Campos M, Simone B, Balasegaram S, Wright A, Usdin M, Lamagni T.
    Epidemiol Infect; 2017 Oct 29; 145(13):2759-2765. PubMed ID: 28805176
    [Abstract] [Full Text] [Related]

  • 45. Severe community-acquired pneumonia due to Streptococcus pyogenes in the Newcastle area.
    Wilson PA, Varadhan H.
    Commun Dis Intell (2018); 2020 Oct 15; 44():. PubMed ID: 33081654
    [Abstract] [Full Text] [Related]

  • 46. Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections.
    Paspaliari DK, Sarvikivi E, Ollgren J, Vuopio J.
    Euro Surveill; 2023 Aug 15; 28(31):. PubMed ID: 37535473
    [Abstract] [Full Text] [Related]

  • 47. Increasing Incidence of Invasive Group A Streptococcus Disease in First Nations Population, Alberta, Canada, 2003-2017.
    Tyrrell GJ, Bell C, Bill L, Fathima S.
    Emerg Infect Dis; 2021 Feb 15; 27(2):443-451. PubMed ID: 33496247
    [Abstract] [Full Text] [Related]

  • 48. High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada.
    Athey TB, Teatero S, Sieswerda LE, Gubbay JB, Marchand-Austin A, Li A, Wasserscheid J, Dewar K, McGeer A, Williams D, Fittipaldi N.
    J Clin Microbiol; 2016 Jan 15; 54(1):83-92. PubMed ID: 26491184
    [Abstract] [Full Text] [Related]

  • 49. Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges.
    Abo YN, Oliver J, McMinn A, Osowicki J, Baker C, Clark JE, Blyth CC, Francis JR, Carr J, Smeesters PR, Crawford NW, Steer AC.
    Lancet Reg Health West Pac; 2023 Dec 15; 41():100873. PubMed ID: 38223399
    [Abstract] [Full Text] [Related]

  • 50. Outbreak of Invasive Group A Streptococcus in Children-Colorado, October 2022-April 2023.
    Ho EC, Cataldi JR, Silveira LJ, Birkholz M, Loi MM, Osborne CM, Dominguez SR.
    J Pediatric Infect Dis Soc; 2023 Oct 28; 12(10):540-548. PubMed ID: 37792995
    [Abstract] [Full Text] [Related]

  • 51. Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016.
    Couture-Cossette A, Carignan A, Mercier A, Desruisseaux C, Valiquette L, Pépin J.
    PLoS One; 2018 Oct 28; 13(10):e0206289. PubMed ID: 30352091
    [Abstract] [Full Text] [Related]

  • 52. Invasive Community-Onset Gram-Positive Infections From July 2018 Through December 2022 at 2 Children's Hospitals.
    Engstrom EE, Plattner AS, McNeil JC, Hulten KG, Reich PJ, Boyle MG, Dunn JJ, Fritz SA, Kaplan SL.
    Open Forum Infect Dis; 2023 Nov 28; 10(11):ofad563. PubMed ID: 38023538
    [Abstract] [Full Text] [Related]

  • 53. Epidemiology of invasive group A streptococcal infections in Norway 2010-2014: A retrospective cohort study.
    Naseer U, Steinbakk M, Blystad H, Caugant DA.
    Eur J Clin Microbiol Infect Dis; 2016 Oct 28; 35(10):1639-48. PubMed ID: 27311458
    [Abstract] [Full Text] [Related]

  • 54. Characterisation of clinical manifestations and treatment strategies for invasive beta-haemolytic streptococcal infections in a Swiss tertiary hospital.
    Neff A, Chok L, von Both U, Matt U, Tarnutzer A, Andreoni F, van der Linden M, Plock JA, Bühler PK, Brugger SD, Schüpbach RA, Zbinden R, Zinkernagel AS.
    Swiss Med Wkly; 2020 Nov 30; 150():w20378. PubMed ID: 33277914
    [Abstract] [Full Text] [Related]

  • 55. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
    Cortés-Penfield N, Ryder JH.
    Clin Infect Dis; 2023 Jan 13; 76(2):346-350. PubMed ID: 36056891
    [Abstract] [Full Text] [Related]

  • 56. Invasive group A streptococcal disease in Hawke's Bay, New Zealand: epidemiology, manifestations and impact.
    Birrell JM, Wilson B, Taylor S, Bennett J.
    N Z Med J; 2023 May 12; 136(1575):33-41. PubMed ID: 37167938
    [Abstract] [Full Text] [Related]

  • 57. High Incidence of Invasive Group A Streptococcal Infections in Remote Indigenous Communities in Northwestern Ontario, Canada.
    Bocking N, Matsumoto CL, Loewen K, Teatero S, Marchand-Austin A, Gordon J, Fittipaldi N, McGeer A.
    Open Forum Infect Dis; 2017 May 12; 4(1):ofw243. PubMed ID: 28480241
    [Abstract] [Full Text] [Related]

  • 58. Socio-environmental and clinical features of invasive group A streptococcal disease in the Northern Territory of Australia.
    Birrell JM, Currie BJ, Abeyaratne A, Majoni SW, Boyd R.
    Commun Dis Intell (2018); 2023 Jul 27; 47():. PubMed ID: 37817299
    [Abstract] [Full Text] [Related]

  • 59. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
    Vilhonen J, Vuopio J, Vahlberg T, Gröndahl-Yli-Hannuksela K, Rantakokko-Jalava K, Oksi J.
    Eur J Clin Microbiol Infect Dis; 2020 Jul 27; 39(7):1339-1348. PubMed ID: 32096108
    [Abstract] [Full Text] [Related]

  • 60. Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series.
    Peetermans M, Matheeussen V, Moerman C, De Rydt F, Thieren S, Pollet E, Casaer M, De Backer B, De Paep R, Debaveye Y, Desmet L, Desmet S, Duval EIM, Fraipont V, Geysels D, Hermans G, Lahaye F, Mathy X, Meersseman P, Meex C, Van Herck J, van Kleef-van Koeveringe S, Layios N, Wauters J, Jorens PG.
    Ann Intensive Care; 2024 Jan 29; 14(1):19. PubMed ID: 38286885
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.